The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks mixed as oil majors, miners lift FTSE 100

Mon, 11th Oct 2021 17:08

(Alliance News) - Stocks in London ended mixed on Monday with the FTSE 100 getting a boost from heavyweight oil majors and mining companies, while on AIM, fast fashion retailers bore the brunt of ASOS's woes.

The FTSE 100 index closed up 51.30 points, or 0.7%, at 7,146.85. The FTSE 250 ended down 48.70 points, or 0.2%, at 22,487.47 and the AIM All-Share closed down 2.48 points, or 0.2%, at 1,209.05.

The Cboe UK 100 ended up 0.5% at 708.80, the Cboe UK 250 closed down 0.5% at 20,281.30 and the Cboe Small Companies ended flat at 15,531.60.

In Paris, the CAC 40 stock index ended up 0.1%, while the DAX 40 in Frankfurt ended down 0.1%.

"The FTSE 100 has outperformed largely due to outperformance in financials and basic resources, while the FTSE 250 has slipped. Rising aluminium and copper prices are helping to push the likes of Anglo American, Antofagasta and the big Australian miners of Rio Tinto and BHP higher, while oil prices above USD80 a barrel are also giving a lift to BP and Royal Dutch Shell," said Michael Hewson of CMC Markets.

In the FTSE 100, miners were higher amid higher base metal prices. Anglo American closed up 5.2%, Antofagasta up 4.3%, Rio Tinto up 3.6%, Glencore up 3.3% and BHP up 3.2%.

Oil majors also ended among the best performers, tracking spot oil prices higher. BP closed up 1.9%, while Royal Dutch Shell 'A' and 'B' closed up 1.7% and 1.5% respectively.

Brent oil was trading at USD83.77 a barrel at the equities close on Monday, up sharply from USD83.15 at the close Friday.

"Oil prices are rising once again today, up a little over 2%, and hitting fresh highs as the energy crisis continues to drive support for crude. The flooding in China may have given oil an extra lift on Monday, but we're looking at a tight market that OPEC+ is allowing to run hot after a long period of low prices," explained Oanda Markets analyst Craig Erlam.

AstraZeneca finished 1.3% higher after the Anglo-Swedish drugmaker said its long-acting antibody combination reduced severe Covid-19 or death in patients with mild-to-moderate symptoms.

The trial met its primary endpoint, with a dose of AZD7442 cutting the risk of developing severe Covid or death by 50% compared to placebo in outpatients who had been symptomatic for seven days or less. A total of 90% of the participants enrolled for the Tackle phase three study were from populations at high risk of progression to severe Covid-19, including those with co-morbidities.

AstraZeneca said it will be discussing the data with health authorities, having last week announced the submission of a request to the US Food & Drug Administration for emergency use authorisation for AZD7442.

On AIM, ASOS closed down 12% after the online fashion retailer said Chief Executive Nick Beighton is stepping down, as it warned on profit in the year ahead due to cost pressures and the falling away of Covid-19-related benefits.

Revenue for the financial year to August 31 jumped 20% to GBP3.91 billion as retail sales grew 19% to GBP3.78 billion, while pretax profit rose 25% to GBP177.1 million. However, sales growth in the year ahead is expected to be in the range of 10% to 15%, with interim revenue growth in "mid-single digits".

This reflects tougher comparatives and industry-wide supply chain pressures. The company expects sales to accelerate in the second half of the year and has laid out plans to generate GBP7 billion of annual revenue over the medium-term.

Adjusted pretax profit for the 2022 financial year is expected around GBP110 million to GBP140 million. This would be well below the GBP193.6 million registered for the financial year just ended.

ASOS shook up its board to "underpin delivery of the next phase of its global growth strategy". CEO Beighton is stepping down after 12 years with ASOS, including six as CEO, and a search is underway for his replacement.

AIM-listed rivals boohoo Group and Quiz closed down 1.1% and 4.3% respectively in a negative read-across.

The pound was quoted at USD1.3625 at the London equities close, down from USD1.3645 at the same time on Friday.

The euro stood at USD1.1570 at the European equities close, down from USD1.1578 late Friday.

Against the yen, the dollar was trading at JPY113.28, up sharply from JPY112.03 late Friday - its highest level since late 2018.

Stocks in New York were higher at the London equities close as earnings season gets underway this week.

The Dow Jones Industrial Average was up 0.4%, the S&P 500 index up 0.4% and the Nasdaq Composite up 0.5%.

This week's calendar includes an update on US consumer prices, as well as earnings reports from JPMorgan Chase and other leading banks.

Gold stood at USD1,758.25 an ounce at the London equities close, little changed from USD1,759.55 late Friday.

The economic events calendar on Tuesday has UK labour market data at 0700 BST and Germany ZEW survey prints at 1000 BST.

The UK corporate calendar on Tuesday has third-quarter results from gambling firm Entain and a trading statement from transport company Stagecoach Group.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.